Moore R - Search Results

1

Characterization of the type III capsular polysaccharide produced by Burkholderia pseudomallei.

Reckseidler-Zenteno SL, Viteri DF, Moore R, Wong E, Tuanyok A, Woods DE. Reckseidler-Zenteno SL, et al. Among authors: moore r. J Med Microbiol. 2010 Dec;59(Pt 12):1403-1414. doi: 10.1099/jmm.0.022202-0. Epub 2010 Aug 19. J Med Microbiol. 2010. PMID: 20724509

2

Genetics and function of the capsules of Burkholderia pseudomallei and their potential as therapeutic targets.

Reckseidler-Zenteno SL, Moore R, Woods DE. Reckseidler-Zenteno SL, et al. Among authors: moore r. Mini Rev Med Chem. 2009 Feb;9(2):265-71. doi: 10.2174/138955709787316047. Mini Rev Med Chem. 2009. PMID: 19200030 Review.

3

Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei.

Moore RA, Reckseidler-Zenteno S, Kim H, Nierman W, Yu Y, Tuanyok A, Warawa J, DeShazer D, Woods DE. Moore RA, et al. Infect Immun. 2004 Jul;72(7):4172-87. doi: 10.1128/IAI.72.7.4172-4187.2004. Infect Immun. 2004. PMID: 15213162 Free PMC article.

4

Genome-wide expression analysis of iron regulation in Burkholderia pseudomallei and Burkholderia mallei using DNA microarrays.

Tuanyok A, Kim HS, Nierman WC, Yu Y, Dunbar J, Moore RA, Baker P, Tom M, Ling JM, Woods DE. Tuanyok A, et al. FEMS Microbiol Lett. 2005 Nov 15;252(2):327-35. doi: 10.1016/j.femsle.2005.09.043. Epub 2005 Oct 10. FEMS Microbiol Lett. 2005. PMID: 16242861

5

The mviN homolog in Burkholderia pseudomallei is essential for viability and virulence.

Ling JM, Moore RA, Surette MG, Woods DE. Ling JM, et al. Can J Microbiol. 2006 Sep;52(9):831-42. doi: 10.1139/w06-042. Can J Microbiol. 2006. PMID: 17110975

6

Survival of Burkholderia pseudomallei in water.

Moore RA, Tuanyok A, Woods DE. Moore RA, et al. BMC Res Notes. 2008 May 7;1:11. doi: 10.1186/1756-0500-1-11. BMC Res Notes. 2008. PMID: 18710531 Free PMC article.

7

Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition.

Tribuddharat C, Moore RA, Baker P, Woods DE. Tribuddharat C, et al. Antimicrob Agents Chemother. 2003 Jul;47(7):2082-7. doi: 10.1128/AAC.47.7.2082-2087.2003. Antimicrob Agents Chemother. 2003. PMID: 12821450 Free PMC article.

8

Cellular reporter screens for inhibitors of Burkholderia pseudomallei targets in Pseudomonas aeruginosa.

Moir DT, Di M, Moore RA, Schweizer HP, Woods DE. Moir DT, et al. Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1(Suppl 1):S152-62. doi: 10.1016/S0035-9203(08)70033-6. Trans R Soc Trop Med Hyg. 2008. PMID: 19121678 Free PMC article.

9

Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei.

Moore RA, DeShazer D, Reckseidler S, Weissman A, Woods DE. Moore RA, et al. Antimicrob Agents Chemother. 1999 Mar;43(3):465-70. doi: 10.1128/AAC.43.3.465. Antimicrob Agents Chemother. 1999. PMID: 10049252 Free PMC article.

10

Development and application of a cellular, gain-of-signal, bioluminescent reporter screen for inhibitors of type II secretion in Pseudomonas aeruginosa and Burkholderia pseudomallei.

Moir DT, Di M, Wong E, Moore RA, Schweizer HP, Woods DE, Bowlin TL. Moir DT, et al. J Biomol Screen. 2011 Aug;16(7):694-705. doi: 10.1177/1087057111408605. Epub 2011 May 20. J Biomol Screen. 2011. PMID: 21602485 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,391 results

Search Page

Filters